Long-term effects of botulinum toxin on neuromuscular function

Anesthesiology

Volumn 106, Issue 6, 2007, Pages 1139-1146

  Frick, Christiane G ^a,b,d   Richtsfeld, Martina ^a,b   Sahani, Nita D ^a   Kaneki, Masao ^a   Blobner, Manfred ^b   Martyn, J A Jeevendra ^a,c,d  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM; BOTULINUM TOXIN; BOTULINUM TOXIN A; NICOTINIC RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTHOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MUSCLE LEVEL; MALE; MUSCLE ATROPHY; MUSCLE DENERVATION; MUSCLE FUNCTION; MUSCLE MASS; MUSCLE TETANIC CONTRACTION; MUSCLE TONE; NERVE POTENTIAL; NEUROMUSCULAR FUNCTION; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; SKELETAL MUSCLE; STATISTICAL SIGNIFICANCE; STEADY STATE; TETANY; TIBIALIS MUSCLE;

ANIMALS; ATRACURIUM; BOTULINUM TOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MUSCLE CONTRACTION; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

EID: 34249689162     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/01.anes.0000267597.65120.16     Document Type: Article

References (39)

1. McDonald LC, Killgore GE, Thompson A, Owens RC Jr, Kazakova SV, Sambol SP, Johnson S, Gerding DN: An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-41
2. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353:2442-9
3. Fischer M, Bhatnagar J, Guarner J, Reagan S, Hacker JK, Van Meter SH, Poukens V, Whiteman DB, Iton A, Cheung M, Dassey DE, Shieh WJ, Zaki SR: Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353:2352-60
4. Barbier J, Popoff MR, Molgo J: Degeneration and regeneration of murine skeletal neuromuscular junctions after intramuscular injection with a sublethal dose of Clostridium sordellii lethal toxin. Infect Immun 2004; 72:3120-8
5. Sugimoto N, Miyamoto A, Horiguchi Y, Okabe T, Matsuda M: Inhibition of neuromuscular transmission in isolated mouse phrenic nerve-diaphragm by the enterotoxin of Clostridium perfringens type A. Toxicon 1992; 30:825-34
6. FitzGerald S, Lyons R, Ryan J, Hall W, Gallagher C: Botulism as a cause of respiratory failure in injecting drug users. Ir J Med Sci 2003; 172:143-4
7. Chakravarty EF, Kirsch CM, Jensen WA, Kagawa FT: Cardiac arrest due to succinylcholine-induced hyperkalemia in a patient with wound botulism. J Clin Anesth 2000; 12:80-2
8. Gordon RJ, Lowy FD: Bacterial infections in drug users. N Engl J Med 2005; 353:1945-54
9. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jernigan DB, Archibald LK: Clostridium infections associated with musculoskeletal-tissue allografts. N Engl J Med 2004; 350:2564-71
10. Patel R, Trampuz A: Infections transmitted through musculoskeletal-tissue allografts. N Engl J Med 2004; 350:2544-6
11. Arnon SS, Schechter R, Maslanka SE, Jewell NP, Hatheway CL: Human botulism immune globulin for the treatment of infant botulism. N Engl J Med 2006; 354:462-71
12. Simpson LL: Identification of the major steps in botulinum toxin action. Annu Rev Pharmacol Toxicol 2004; 44:167-93
13. Turton K, Chaddock JA, Acharya KR: Botulinum and tetanus neurotoxins: Structure, function and therapeutic utility. Trends Biochem Sci 2002; 27:552-8
14. Karwa M, Currie B, Kvetan V: Bioterrorism: Preparing for the impossible or the improbable. Crit Care Med 2005; 33:S75-95
15. Brin MF: Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Suppl 1997; 6:S146-68
16. Schurch B: The role of botulinum toxin in neurourology. Drugs Today (Barc) 2004; 40:205-12
17. Schurch B, Reitz A: Botulinum toxin in urology: Indications and results. Urologe A 2004; 43:1410-5
18. Swartling C, Farnstrand C, Abt G, Stalberg E, Naver H: Side-effects of intradermal injections of botulinum A toxin in the treatment of palmar hyperhidrosis: A neurophysiological study. Eur J Neurol 2001; 8:451-6
19. Olney RK, Aminoff MJ, Gelb DJ, Lowenstein DH: Neuromuscular effects distant from the site of botulinum toxin injection. Neurology 1988; 38:1780-3
20. Lange DL, Rubin M, Greene PE, Kang J, Moskowitz CB, Brin MF: Distant effects of locally injected botulinum toxin: A double-blind study of single fiber EMG changes. Muscle Nerve 1991; 14:672-5
21. Billante CR, Zealear DL, Billante M, Reyes JH, Sant'Anna G, Rodriguez R, Stone RE Jr: Comparison of neuromuscular blockade and recovery with botulinum toxins A and F. Muscle Nerve 2002; 26:395-403
22. Witzemann V, Brenner HR, Sakmann B: Neural factors regulate AChR subunit mRNAs at rat neuromuscular synapses. J Cell Biol 1991; 114:125-41
23. Thesleff S, Molgo J, Tagerud S: Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins. J Physiol (Paris) 1990; 84:167-73
24. Ibebunjo C, Martyn JAJ: Thermal injury induces greater resistance to d-tubocurarine in local rather than in distant muscles in the rat. Anesth Analg 2000; 91:1243-9
25. Fink H, Luppa P, Mayer B, Rosenbrock H, Metzger J, Martyn JAJ, Blobner M: Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors. ANESTHESIOLOGY 2003; 98:82-8
26. Montecucco C, Schiavo G: Structure and function of tetanus and botulinum neurotoxins. Q Rev Biophys 1995; 28:423-72
27. Rowland LP: Stroke, spasticity, and botulinum toxin. N Engl J Med 2002; 347:382-3
28. Meunier FA, Schiavo G, Molgo J: Botulinum neurotoxins: From paralysis to recovery of functional neuromuscular transmission. J Physiol Paris 2002; 96:105-13
29. Wang X, Engish KL, Teichert RW, Olivera BM, Pinter MJ, Rich MM: Prolongation of evoked and spontaneous synaptic currents at the neuromuscular junction after activity blockade is caused by the up-regulation of fetal acetylcholine receptors. J Neurosci 2006; 26:8983-87
30. Wang X, Li Y, Engisch KL, Nakanishi ST, Dodson SE, Miller GW, Cope TC, Pinter MJ, Rich MM: Activity-dependent presynaptic regulation of quantal size at the mammalian neuromuscular junction in vivo. J Neurosci 2005; 25:343-51
31. Hogue CW Jr, Itani MS, Martyn JAJ: Resistance to d-tubocurarine in lower motor neuron injury is related to increased acetylcholine receptors at the neuromuscular junction. ANESTHESIOLOGY 1990; 73:703-9
32. Martyn JAJ, White DA, Gronert GA, Jaffe RS, Ward JM: Up-and-down regulation of skeletal muscle acetylcholine receptors: Effects on neuromuscular blockers. ANESTHESIOLOGY 1992; 76:822-43
33. Ibebunjo C, Nosek MT, Itani MS, Martyn JAJ: Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy. J Pharmacol Exp Ther 1997; 283:443-51
34. Martyn JAJ, Richtsfeld M: Succinylcholine-induced hyperkalemia in acquired pathologic states: Etiologic factors and molecular mechanisms. ANESTHESIOLOGY 2006; 104:158-69
35. Tsuneki H, Salas R, Dani JA: Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology. J Physiol 2003; 547:169-79
36. Kopman AF, Klewicka MM, Neuman GG: An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs. Anesth Analg 2000; 90:1191-7
37. Kohlschutter B, Baur H, Roth F: Suxamethonium-induced hyperkalaemia in patients with severe intra-abdominal infections. Br J Anaesth 1976; 48:557-62
38. Sarubin J, Gebert E: Serum potassium rise following depolarizing muscle relaxants in immobilized patients [author's transl.]. Anaesthesist 1981; 30:246-50
39. Miller L: Neuromuscular blockade monitoring complicated by the unknown preoperative cosmetic use of botulinum toxin. ANESTHESIOLOGY 2006; 105:862